Strategic Expansion Strategy Is Boosting ImmunityBio (IBRX) Shares
Following the announcement of a significant growth strategy, ImmunityBio, Inc. (NASDAQ: IBRX) has experienced a notable increase in its stock value. As of the latest session, IBRX shares have risen by 11.56%, reaching $6.95. Initiation Of ANKTIVA Therapy In The US ImmunityBio (IBRX) has initiated the treatment of multiple patients in the United States with […]